Abstract
Background: In several studies, Vitamin D supplementation was found useful against the highly infectious SARS-CoV-2 to reduce the mortality rate and severity of its infection. Viral replication was also found to be affected negatively by vitamin D administration.
Objective: The literature was reviewed with an aim to evaluate the efficacy of the therapeutic approach of nutrition involving intervention of Vitamin D towards decreasing the severity of prevailing pandemic of SARS-CoV-2.
Methods: A background research of literature was performed using the keywords “SARS-CoV- 2”, “COVID-19”, “nutritional therapy”, “Vitamin D”, “immunity”, “AEC2 receptors” and “RAS” in the Pubmed and Google Scholar.
Results: This literature was review suggested that if combined with medical sciences, this nutritional therapy approach can end up as an influential solution to reduce the severity of SARSCoV- 2 infection, which is a prevailing pandemic. A combination of assessment, supplementation of this required micro-nutrient (Vitamin D), and monitoring can be used to aid the immune system of COVID-19 patients.
Conclusion: Nutritional therapy with Vitamin D as a major factor can be used to increase the immunity of an individual to fight against the highly infectious SARS-CoV-2. However, the actual mechanism of how Vitamin D supplementation functions to improve the health of an individual is yet unclear.
Keywords: SARS-CoV-2, Covid-19, Nutritional therapy, Vitamin D, Immunity, AEC2 receptors, RAS.
Graphical Abstract
[1]
Gorbalenya AE, Baker SC, Baric R, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group BioRxiv: 2020.
[http://dx.doi.org/10.1101/2020.02.07.937862]
[http://dx.doi.org/10.1101/2020.02.07.937862]
[2]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[3]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[4]
Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr 2020; 51: 102083.
[http://dx.doi.org/10.1016/j.ajp.2020.102083] [PMID: 32283510]
[http://dx.doi.org/10.1016/j.ajp.2020.102083] [PMID: 32283510]
[5]
Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12(4): 988.
[http://dx.doi.org/10.3390/nu12040988] [PMID: 32252338]
[http://dx.doi.org/10.3390/nu12040988] [PMID: 32252338]
[6]
Vyas N, Kurian SJ, Bagchi D, et al. Vitamin D in prevention and treatment of COVID-19: Current perspective and future prospects. J Am Coll Nutr 2021; 40(7): 632-45.
[http://dx.doi.org/10.1080/07315724.2020.1806758] [PMID: 32870735]
[http://dx.doi.org/10.1080/07315724.2020.1806758] [PMID: 32870735]
[7]
Brugliera L, Spina A, Castellazzi P, et al. Nutritional management of COVID-19 patients in a rehabilitation unit. Eur J Clin Nutr 2020; 74(6): 860-3.
[http://dx.doi.org/10.1038/s41430-020-0664-x] [PMID: 32433599]
[http://dx.doi.org/10.1038/s41430-020-0664-x] [PMID: 32433599]
[8]
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH across Speciality Collaboration, UK. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229): 1033-4.
[http://dx.doi.org/10.1016/S0140-6736(20)30628-0] [PMID: 32192578]
[http://dx.doi.org/10.1016/S0140-6736(20)30628-0] [PMID: 32192578]
[9]
Jiang X, Rayner S, Luo MH. Does SARS-CoV-2 has a longer incubation period than SARS and MERS? J Med Virol 2020; 92(5): 476-8.
[http://dx.doi.org/10.1002/jmv.25708] [PMID: 32056235]
[http://dx.doi.org/10.1002/jmv.25708] [PMID: 32056235]
[10]
Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy 2020; 5(1): 6.
[http://dx.doi.org/10.1186/s41256-020-00135-6] [PMID: 32226823]
[http://dx.doi.org/10.1186/s41256-020-00135-6] [PMID: 32226823]
[11]
Goldsmith CS, Tatti KM, Ksiazek TG, et al. Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 2004; 10(2): 320-6.
[http://dx.doi.org/10.3201/eid1002.030913] [PMID: 15030705]
[http://dx.doi.org/10.3201/eid1002.030913] [PMID: 15030705]
[12]
Chhikara BS, Rathi B, Singh J, Poonam FNU. Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chemical Biology Letters 2020; 7(1): 63-72.
[13]
Wang LF, Shi Z, Zhang S, Field H, Daszak P, Eaton BT. Review of bats and SARS. Emerg Infect Dis 2006; 12(12): 1834-40.
[http://dx.doi.org/10.3201/eid1212.060401] [PMID: 17326933]
[http://dx.doi.org/10.3201/eid1212.060401] [PMID: 17326933]
[14]
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367(6485): 1444-8.
[http://dx.doi.org/10.1126/science.abb2762] [PMID: 32132184]
[http://dx.doi.org/10.1126/science.abb2762] [PMID: 32132184]
[15]
Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clin Med 2020; 24: 100433.
[http://dx.doi.org/10.1016/j.eclinm.2020.100433] [PMID: 32766542]
[http://dx.doi.org/10.1016/j.eclinm.2020.100433] [PMID: 32766542]
[16]
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623.
[http://dx.doi.org/10.1016/j.tmaid.2020.101623] [PMID: 32179124]
[http://dx.doi.org/10.1016/j.tmaid.2020.101623] [PMID: 32179124]
[17]
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect 2020; 80(6): e14-8.
[http://dx.doi.org/10.1016/j.jinf.2020.03.005] [PMID: 32171866]
[http://dx.doi.org/10.1016/j.jinf.2020.03.005] [PMID: 32171866]
[18]
Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 2020; 43(7): 1399-407.
[http://dx.doi.org/10.2337/dc20-0660] [PMID: 32409498]
[http://dx.doi.org/10.2337/dc20-0660] [PMID: 32409498]
[19]
Rao S, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: A Mendelian Randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care 2020; 43(7): 1416-26.
[http://dx.doi.org/10.2337/dc20-0643] [PMID: 32430459]
[http://dx.doi.org/10.2337/dc20-0643] [PMID: 32430459]
[20]
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell LF, Chernyak Y. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv 2020; 369: m1966.
[http://dx.doi.org/10.1136/bmj.m1966]
[http://dx.doi.org/10.1136/bmj.m1966]
[21]
Kyle UG, Bosaeus I, De Lorenzo AD, et al. Composition of the ESPEN Working Group. Bioelectrical impedance analysis-part I: Review of principles and methods. Clin Nutr 2004; 23(5): 1226-43.
[http://dx.doi.org/10.1016/j.clnu.2004.06.004] [PMID: 15380917]
[http://dx.doi.org/10.1016/j.clnu.2004.06.004] [PMID: 15380917]
[22]
Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 2019; 38(1): 10-47.
[http://dx.doi.org/10.1016/j.clnu.2018.05.024] [PMID: 30005900]
[http://dx.doi.org/10.1016/j.clnu.2018.05.024] [PMID: 30005900]
[23]
Caccialanza R, Laviano A, Lobascio F, et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition 2020; 74: 110835.
[http://dx.doi.org/10.1016/j.nut.2020.110835] [PMID: 32280058]
[http://dx.doi.org/10.1016/j.nut.2020.110835] [PMID: 32280058]
[24]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[25]
Barazzoni R, Bischoff SC, Breda J, et al. endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr 2020; 39(6): 1631-8.
[http://dx.doi.org/10.1016/j.clnu.2020.03.022] [PMID: 32305181]
[http://dx.doi.org/10.1016/j.clnu.2020.03.022] [PMID: 32305181]
[26]
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G, Vitamin D. Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 2016; 96(1): 365-408.
[http://dx.doi.org/10.1152/physrev.00014.2015] [PMID: 26681795]
[http://dx.doi.org/10.1152/physrev.00014.2015] [PMID: 26681795]
[27]
Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. J Autoimmun 2017; 85: 78-97.
[http://dx.doi.org/10.1016/j.jaut.2017.07.007] [PMID: 28733125]
[http://dx.doi.org/10.1016/j.jaut.2017.07.007] [PMID: 28733125]
[28]
Luo X, Liao Q, Shen Y, Li H, Cheng L. Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. J Nutr 2021; 151(1): 98-103.
[http://dx.doi.org/10.1093/jn/nxaa332] [PMID: 33188401]
[http://dx.doi.org/10.1093/jn/nxaa332] [PMID: 33188401]
[29]
Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169(4): 384-90.
[http://dx.doi.org/10.1001/archinternmed.2008.560] [PMID: 19237723]
[http://dx.doi.org/10.1001/archinternmed.2008.560] [PMID: 19237723]
[30]
D’Avolio A, Avataneo V, Manca A, et al. 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 2020; 12(5): 1359.
[http://dx.doi.org/10.3390/nu12051359] [PMID: 32397511]
[http://dx.doi.org/10.3390/nu12051359] [PMID: 32397511]
[31]
Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D deficiency and treatment with COVID-19 incidence. medRxiv 2020; Preprint.
[http://dx.doi.org/10.1101/2020.05.08.20095893]
[http://dx.doi.org/10.1101/2020.05.08.20095893]
[32]
Khan AH, Nasir N, Nasir N, Maha Q, Rehman R. Vitamin D and COVID-19: Is there a role? J Diabetes Metab Disord 2021; 20(1): 1-8.
[http://dx.doi.org/10.1007/s40200-021-00775-6] [PMID: 33816359]
[http://dx.doi.org/10.1007/s40200-021-00775-6] [PMID: 33816359]
[33]
Herwig R, Panhofer TP, Greilberger M, Greilberger J. A novel vitamin D based substance, plus AlphaH P lead to complete recovery from COVID-19 within 48 hours after application in a 7-months old baby, a 1.5-year-old toddler and three further adults. J Transl Sci 2020; 7: 1-10.
[34]
Ma H, Zhou T, Heianza Y, Qi L. Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: A prospective study in UK Biobank. Am J Clin Nutr 2021; 113(5): 1275-81.
[http://dx.doi.org/10.1093/ajcn/nqaa381] [PMID: 33515005]
[http://dx.doi.org/10.1093/ajcn/nqaa381] [PMID: 33515005]
[35]
Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr 2010; 99(3): 389-93.
[http://dx.doi.org/10.1111/j.1651-2227.2009.01594.x] [PMID: 19900174]
[http://dx.doi.org/10.1111/j.1651-2227.2009.01594.x] [PMID: 19900174]
[36]
Inamo Y, Hasegawa M, Saito K, et al. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr Int 2011; 53(2): 199-201.
[http://dx.doi.org/10.1111/j.1442-200X.2010.03224.x] [PMID: 21648117]
[http://dx.doi.org/10.1111/j.1442-200X.2010.03224.x] [PMID: 21648117]
[37]
Hariyanto TI, Intan D, Hananto JE, Harapan H, Kurniawan A. Vitamin D supplementation and COVID‐19 outcomes: A systematic review, meta‐analysis and meta‐regression. Rev Med Virol 2021; e2269.
[http://dx.doi.org/10.1002/rmv.2269]
[http://dx.doi.org/10.1002/rmv.2269]
[38]
Tan CW, Ho LP, Kalimuddin S, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 2020; 79-80: 111017.
[http://dx.doi.org/10.1016/j.nut.2020.111017] [PMID: 33039952]
[http://dx.doi.org/10.1016/j.nut.2020.111017] [PMID: 33039952]
[39]
Rastogi A, Bhansali A, Khare N, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study). Postgrad Med J 2022; 98: 87-90.
[http://dx.doi.org/10.1136/postgradmedj-2020-139065]
[http://dx.doi.org/10.1136/postgradmedj-2020-139065]
[40]
Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune System-Working in harmony to reduce the risk of infection. Nutrients 2020; 12(1): 236.
[http://dx.doi.org/10.3390/nu12010236] [PMID: 31963293]
[http://dx.doi.org/10.3390/nu12010236] [PMID: 31963293]
[41]
Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv 2020.
[http://dx.doi.org/10.1101/2020.01.31.929042]
[http://dx.doi.org/10.1101/2020.01.31.929042]
[42]
Jovic TH, Ali SR, Ibrahim N, et al. Could vitamins help in the fight against COVID-19? Nutrients 2020; 12(9): 2550.
[http://dx.doi.org/10.3390/nu12092550] [PMID: 32842513]
[http://dx.doi.org/10.3390/nu12092550] [PMID: 32842513]
[43]
Bajwa EK, Bhan I, Quraishi S, Matthay M, Thompson BT. Low vitamin D status occurs in 90% of patients with ARDS and is associated with longer duration of mechanical ventilation. In: Am J Respir Crit Care Med 2016; 193: p. A1846.
[44]
Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide induced acute lung injury via regulation of the renin angiotensin system. Mol Med Rep 2017; 16(5): 7432-8.
[http://dx.doi.org/10.3892/mmr.2017.7546] [PMID: 28944831]
[http://dx.doi.org/10.3892/mmr.2017.7546] [PMID: 28944831]
[45]
Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436(7047): 112-6.
[http://dx.doi.org/10.1038/nature03712] [PMID: 16001071]
[http://dx.doi.org/10.1038/nature03712] [PMID: 16001071]
[46]
Ebadi M, Montano-Loza AJ. Perspective: Improving vitamin D status in the management of COVID-19. Eur J Clin Nutr 2020; 74(6): 856-9.
[http://dx.doi.org/10.1038/s41430-020-0661-0] [PMID: 32398871]
[http://dx.doi.org/10.1038/s41430-020-0661-0] [PMID: 32398871]
[47]
Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19(2): 265-9.
[http://dx.doi.org/10.1359/jbmr.2004.19.2.265] [PMID: 14969396]
[http://dx.doi.org/10.1359/jbmr.2004.19.2.265] [PMID: 14969396]
[48]
Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol 2020; 31(5): 454-70.
[http://dx.doi.org/10.1111/pai.13271] [PMID: 32359201]
[http://dx.doi.org/10.1111/pai.13271] [PMID: 32359201]
[49]
Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183(9): 5458-67.
[http://dx.doi.org/10.4049/jimmunol.0803217] [PMID: 19843932]
[http://dx.doi.org/10.4049/jimmunol.0803217] [PMID: 19843932]
[50]
Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.04.08.20058578]
[http://dx.doi.org/10.1101/2020.04.08.20058578]
Article Metrics
1